Exact Mass: 355.1069

Exact Mass Matches: 355.1069

Found 85 metabolites which its exact mass value is equals to given mass value 355.1069, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Avenanthramide P

5-Hydroxy-2-{[(2E,4E)-1-hydroxy-5-(4-hydroxy-3-methoxyphenyl)penta-2,4-dien-1-ylidene]amino}benzoate

C19H17NO6 (355.1056)


   

7,8-Dimethoxy-3-methyl-1-(4-nitrophenyl)-5H-2,3-benzodiazepin-4-one

7,8-dimethoxy-3-methyl-1-(4-nitrophenyl)-4,5-dihydro-3H-2,3-benzodiazepin-4-one

C18H17N3O5 (355.1168)


   

5-methylthiopentyldesulfoglucosinolate

2-{[1-(hydroxyimino)-6-(methylsulphanyl)hexyl]sulphanyl}-6-(hydroxymethyl)oxane-3,4,5-triol

C13H25NO6S2 (355.1123)


5-methylthiopentyldesulfoglucosinolate is a member of the class of compounds known as thioglycosides. Thioglycosides are glycoside in which a sugar group is bonded through one carbon to another group via a S-glycosidic bond. 5-methylthiopentyldesulfoglucosinolate is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 5-methylthiopentyldesulfoglucosinolate can be found in a number of food items such as oval-leaf huckleberry, broad bean, adzuki bean, and cocoa bean, which makes 5-methylthiopentyldesulfoglucosinolate a potential biomarker for the consumption of these food products.

   

5-Methylthiopentyldesulfoglucosinolate

5-Methylthiopentyldesulfoglucosinolate

C13H25NO6S2 (355.1123)


   

_)-3,4-Dihydrolinaresine

_)-3,4-Dihydrolinaresine

C19H17NO6 (355.1056)


   
   

2-[4-(1,3-Dithiolan-2-yl)phenoxy]-N-{[(isopropylamino)carbonyl]oxy}ethanimidamide

2-[4-(1,3-Dithiolan-2-yl)phenoxy]-N-{[(isopropylamino)carbonyl]oxy}ethanimidamide

C15H21N3O3S2 (355.1024)


   
   

Chondrosin|chondrosine

Chondrosin|chondrosine

C12H21NO11 (355.1115)


   
   

3-[2-Methyl-1,2,3,4-tetrahydro-6,7-(methylenebisoxy)isoquinoline-1-yl]-6,7-dihydroxyisobenzofuran-1(3H)-one

3-[2-Methyl-1,2,3,4-tetrahydro-6,7-(methylenebisoxy)isoquinoline-1-yl]-6,7-dihydroxyisobenzofuran-1(3H)-one

C19H17NO6 (355.1056)


   

coryternatine A

coryternatine A

C19H17NO6 (355.1056)


   

Guanosin-propionsaeure|N-(9-beta-D-ribofuranosyl-6-oxo-6,9-dihydro-1H-purin-2-yl)-alanine

Guanosin-propionsaeure|N-(9-beta-D-ribofuranosyl-6-oxo-6,9-dihydro-1H-purin-2-yl)-alanine

C13H17N5O7 (355.1128)


   

4,5-dioxoartacinatine

4,5-dioxoartacinatine

C19H17NO6 (355.1056)


   

desulfo-5-(methylsulfinyl)pentyl GL|desulfoglucoalyssin|DS-GAL

desulfo-5-(methylsulfinyl)pentyl GL|desulfoglucoalyssin|DS-GAL

C13H25NO6S2 (355.1123)


   

debromoantazirine

debromoantazirine

C17H26BrNO2 (355.1147)


   

(+/-)-dihydrolinaresine|Dihydrolinaresine

(+/-)-dihydrolinaresine|Dihydrolinaresine

C19H17NO6 (355.1056)


   

Dracocephin-A

Dracocephin-A

C19H17NO6 (355.1056)


   

O1-(2-amino-2-deoxy-D-galactose-3-yl)-alpha-L-idopyranuronic acid|O1-(2-Amino-2-desoxy-D-galactose-3-yl)-alpha-L-idopyranuronsaeure

O1-(2-amino-2-deoxy-D-galactose-3-yl)-alpha-L-idopyranuronic acid|O1-(2-Amino-2-desoxy-D-galactose-3-yl)-alpha-L-idopyranuronsaeure

C12H21NO11 (355.1115)


   

Oubatchensine

Oubatchensine

C19H17NO6 (355.1056)


   

Methanone, (7,8-dihydro-1,3-dioxolo(4,5-g)isoquinolin-5-yl)(2-hydroxy-3,4-dimethoxyphenyl)-

Methanone, (7,8-dihydro-1,3-dioxolo(4,5-g)isoquinolin-5-yl)(2-hydroxy-3,4-dimethoxyphenyl)-

C19H17NO6 (355.1056)


   
   

Ethacrynic acid M1

Ethacrynic acid M1

C16H21NO6S (355.109)


   

CHONDROSINE

D-Galactose, 2-amino-2-deoxy-3-O-.beta.-D-glucopyranuronosyl-

C12H21NO11 (355.1115)


   

CAY10499

[4-(5-methoxy-2-oxo-1,3,4-oxadiazol-3(2H)-yl)-2-methylphenyl]-carbamic acid, phenylmethyl ester

C18H17N3O5 (355.1168)


MAGL-IN-5 (CAY10499) is a non-selective lipase inhibitor with IC50 values of 144, 90, and 14 nM for human recombinant monoacylglycerol lipase(MAGL),hormone sensitive lipase(HSL), and fatty acid amide hydrolase(FAAH) respectively[1][2].

   
   

Isradipine Metabolite (2,1,3-Benzoxadiazole, 3,5-pyridinedicarboxylic acid deriv.)

3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-, mono(1-methylethyl) ester

C18H17N3O5 (355.1168)


   

fmoc-l-prolyl chloride

fmoc-l-prolyl chloride

C20H18ClNO3 (355.0975)


   

N-(9-Fluorenylmethoxycarbonyl)-L-aspartic acid-1-13C

N-(9-Fluorenylmethoxycarbonyl)-L-aspartic acid-1-13C

C19H17NO6 (355.1056)


   

1-amino-5-hydroxy-4-[(1-methylpropyl)amino]-8-nitroanthraquinone

1-amino-5-hydroxy-4-[(1-methylpropyl)amino]-8-nitroanthraquinone

C18H17N3O5 (355.1168)


   

tinofedrine

tinofedrine

C20H21NOS2 (355.1064)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

9-(4-Acetoxy-3-acetoxymethylbutyl)-2-amino-6-chloropurine

9-(4-Acetoxy-3-acetoxymethylbutyl)-2-amino-6-chloropurine

C14H18ClN5O4 (355.1047)


   

5-[4-[2-[N-Methyl-N-(2-pyridinyl)amino]ethoxy]benzylidene]-2,4-thiazolidinedione

5-[4-[2-[N-Methyl-N-(2-pyridinyl)amino]ethoxy]benzylidene]-2,4-thiazolidinedione

C18H17N3O3S (355.0991)


   

fmoc-asp-oh-15n

fmoc-asp-oh-15n

C19H17NO6 (355.1056)


   
   
   

1-(azetidin-3-yl)-4-(4-methoxyphenyl)piperazine,trihydrochloride

1-(azetidin-3-yl)-4-(4-methoxyphenyl)piperazine,trihydrochloride

C14H24Cl3N3O (355.0985)


   

3-[4-(2-Methoxyphenyl)piperazinyl]azetidine trihydrochloride

3-[4-(2-Methoxyphenyl)piperazinyl]azetidine trihydrochloride

C14H24Cl3N3O (355.0985)


   
   

benzyl 2-(3-imidazol-1-yl-1,2,4-thiadiazol-5-yl)pyrrolidine-1-carboxylate

benzyl 2-(3-imidazol-1-yl-1,2,4-thiadiazol-5-yl)pyrrolidine-1-carboxylate

C17H17N5O2S (355.1103)


   

Norfloxacin hydrochloride

Norfloxacin hydrochloride

C16H19ClFN3O3 (355.1099)


   

N-Succinimidyl 3-(Diphenylphosphino)propionate

N-Succinimidyl 3-(Diphenylphosphino)propionate

C19H18NO4P (355.0973)


   
   

Fmoc-D-Asp-OH

Fmoc-D-Asp-OH

C19H17NO6 (355.1056)


   

{(2z)-4-Amino-2-[(4-Methoxyphenyl)imino]-2,3-Dihydro-1,3-Thiazol-5-Yl}(4-Methoxyphenyl)methanone

{(2z)-4-Amino-2-[(4-Methoxyphenyl)imino]-2,3-Dihydro-1,3-Thiazol-5-Yl}(4-Methoxyphenyl)methanone

C18H17N3O3S (355.0991)


   

2,6-difluoro-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]benzamide

2,6-difluoro-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]benzamide

C19H15F2N3O2 (355.1132)


   

2-[[3-(3,4-Dimethoxyphenyl)-2-oxo-1-benzopyran-7-yl]oxy]acetamide

2-[[3-(3,4-Dimethoxyphenyl)-2-oxo-1-benzopyran-7-yl]oxy]acetamide

C19H17NO6 (355.1056)


   

5-(Methylsulfanyl)pentyl-desulfoglucosinolate

5-(Methylsulfanyl)pentyl-desulfoglucosinolate

C13H25NO6S2 (355.1123)


   

Magl-IN-5

Magl-IN-5

C18H17N3O5 (355.1168)


MAGL-IN-5 (CAY10499) is a non-selective lipase inhibitor with IC50 values of 144, 90, and 14 nM for human recombinant monoacylglycerol lipase(MAGL),hormone sensitive lipase(HSL), and fatty acid amide hydrolase(FAAH) respectively[1][2].

   

1-(2,1,3-Benzothiadiazol-5-yl)-3-[4-(4-morpholinyl)phenyl]urea

1-(2,1,3-Benzothiadiazol-5-yl)-3-[4-(4-morpholinyl)phenyl]urea

C17H17N5O2S (355.1103)


   

n(2)-Carboxyethylguanosine

n(2)-Carboxyethylguanosine

C13H17N5O7 (355.1128)


   

N-tert-butyl-2-[3-(2-chlorophenyl)-1,2,4-oxadiazol-5-yl]benzamide

N-tert-butyl-2-[3-(2-chlorophenyl)-1,2,4-oxadiazol-5-yl]benzamide

C19H18ClN3O2 (355.1087)


   

N-[5-(2,4-dimethoxyphenyl)-1,3,4-thiadiazol-2-yl]-2-phenylacetamide

N-[5-(2,4-dimethoxyphenyl)-1,3,4-thiadiazol-2-yl]-2-phenylacetamide

C18H17N3O3S (355.0991)


   

N-[2-(1-naphthalenyl)-1,3-benzoxazol-5-yl]-1H-1,2,4-triazole-5-carboxamide

N-[2-(1-naphthalenyl)-1,3-benzoxazol-5-yl]-1H-1,2,4-triazole-5-carboxamide

C20H13N5O2 (355.1069)


   

2-[(4-Oxo-2-pyrido[1,2-a]pyrimidinyl)methylthio]-3-pyridinecarboxylic acid propan-2-yl ester

2-[(4-Oxo-2-pyrido[1,2-a]pyrimidinyl)methylthio]-3-pyridinecarboxylic acid propan-2-yl ester

C18H17N3O3S (355.0991)


   

2-[(1-acetyl-2-benzimidazolyl)thio]-N-(2-methoxyphenyl)acetamide

2-[(1-acetyl-2-benzimidazolyl)thio]-N-(2-methoxyphenyl)acetamide

C18H17N3O3S (355.0991)


   

N-(4-methylphenyl)-2-[(4E)-4-[(5-methylthiophen-2-yl)methylidene]-2,5-dioxoimidazolidin-1-yl]acetamide

N-(4-methylphenyl)-2-[(4E)-4-[(5-methylthiophen-2-yl)methylidene]-2,5-dioxoimidazolidin-1-yl]acetamide

C18H17N3O3S (355.0991)


   

1-[2-[(4-Chlorophenyl)thio]-1-oxopropyl]-4-piperidinecarboxylic acid ethyl ester

1-[2-[(4-Chlorophenyl)thio]-1-oxopropyl]-4-piperidinecarboxylic acid ethyl ester

C17H22ClNO3S (355.1009)


   

4-[[3-Cyano-4-methyl-6-(3-pyridinyl)-2-pyridinyl]thio]-3-oxobutanoic acid ethyl ester

4-[[3-Cyano-4-methyl-6-(3-pyridinyl)-2-pyridinyl]thio]-3-oxobutanoic acid ethyl ester

C18H17N3O3S (355.0991)


   

N-(3-methylphenyl)-2-{(4E)-4-[(5-methylthien-2-yl)methylene]-2,5-dioxoimidazolidin-1-yl}acetamide

N-(3-methylphenyl)-2-{(4E)-4-[(5-methylthien-2-yl)methylene]-2,5-dioxoimidazolidin-1-yl}acetamide

C18H17N3O3S (355.0991)


   

3-chloro-4,5-dimethoxy-N-(1-naphthalenylmethyl)benzamide

3-chloro-4,5-dimethoxy-N-(1-naphthalenylmethyl)benzamide

C20H18ClNO3 (355.0975)


   

5-chloro-N-(4-morpholin-4-ylphenyl)-1H-indole-2-carboxamide

5-chloro-N-(4-morpholin-4-ylphenyl)-1H-indole-2-carboxamide

C19H18ClN3O2 (355.1087)


   

(R)-N(2)-carboxyethylguanosine

(R)-N(2)-carboxyethylguanosine

C13H17N5O7 (355.1128)


   

(S)-N(2)-carboxyethylguanosine

(S)-N(2)-carboxyethylguanosine

C13H17N5O7 (355.1128)


   

5-(Methylthio)pentyldesulfoglucosinolate

5-(Methylthio)pentyldesulfoglucosinolate

C13H25NO6S2 (355.1123)


An omega-(methylsulfany)alkyl desulfoglucosinolate in which the omega-(methylsulfany)alkyl group is specified as 5-(methylsulfanyl)pentyl.

   

D-alanylgriseoluteate

D-alanylgriseoluteate

C18H17N3O5 (355.1168)


   

heparosan L-iduronate

heparosan L-iduronate

C12H21NO11 (355.1115)


   

heparosan D-glucuronate

heparosan D-glucuronate

C12H21NO11 (355.1115)


   

heparosan L-iduronic acid

heparosan L-iduronic acid

C12H21NO11 (355.1115)


   

heparosan D-glucuronic acid

heparosan D-glucuronic acid

C12H21NO11 (355.1115)


   

4-O-beta-D-glucosyl-trans-ferulate

4-O-beta-D-glucosyl-trans-ferulate

C16H19O9- (355.1029)


   

6-(2-Aminopropanoyloxymethyl)-9-methoxyphenazine-1-carboxylic acid

6-(2-Aminopropanoyloxymethyl)-9-methoxyphenazine-1-carboxylic acid

C18H17N3O5 (355.1168)


   
   

VU0152099

VU0152099

C18H17N3O3S (355.0991)


VU0152099 is a potent, selective and brain-penetrant mAChR M4 positive allosteric modulator with an EC50 of 0.4 μM for rat M4 receptor. VU0152099 is inactive for other mAChR subtypes or other GPCRs. VU0152099 has no agonist activity but potentiated responses of M4 to acetylcholine[1]. VU0152099 is a potent, selective and brain-penetrant mAChR M4 positive allosteric modulator with an EC50 of 0.4 μM for rat M4 receptor. VU0152099 is inactive for other mAChR subtypes or other GPCRs. VU0152099 has no agonist activity but potentiated responses of M4 to acetylcholine[1].

   

7-[(dimethylamino)methyl]-5,12-dimethoxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione

7-[(dimethylamino)methyl]-5,12-dimethoxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione

C19H17NO6 (355.1056)


   

10-(6,7-dihydroxy-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl)-3,5,11-trioxatricyclo[7.3.0.0²,⁶]dodeca-1(9),2(6),7-trien-12-one

10-(6,7-dihydroxy-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl)-3,5,11-trioxatricyclo[7.3.0.0²,⁶]dodeca-1(9),2(6),7-trien-12-one

C19H17NO6 (355.1056)


   

6-hydroxy-7-methoxy-12-methyl-16,18-dioxa-12-azatetracyclo[11.7.0.0⁴,⁹.0¹⁵,¹⁹]icosa-1(20),4(9),5,7,13,15(19)-hexaene-2,3-dione

6-hydroxy-7-methoxy-12-methyl-16,18-dioxa-12-azatetracyclo[11.7.0.0⁴,⁹.0¹⁵,¹⁹]icosa-1(20),4(9),5,7,13,15(19)-hexaene-2,3-dione

C19H17NO6 (355.1056)


   

(4s)-4-hydroxy-15,16-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1,7,9(17),13,15-pentaene-3,11,12-trione

(4s)-4-hydroxy-15,16-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1,7,9(17),13,15-pentaene-3,11,12-trione

C19H17NO6 (355.1056)


   

1,4,5-trihydroxy-6-{[2-(2-methylbut-3-en-2-yl)indol-3-ylidene]methyl}pyrazine-2,3-dione

1,4,5-trihydroxy-6-{[2-(2-methylbut-3-en-2-yl)indol-3-ylidene]methyl}pyrazine-2,3-dione

C18H17N3O5 (355.1168)


   

(2s,3r,4s,5s,6r)-2-{[(1e)-1-(hydroxyimino)-6-(methylsulfanyl)hexyl]sulfanyl}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1e)-1-(hydroxyimino)-6-(methylsulfanyl)hexyl]sulfanyl}-6-(hydroxymethyl)oxane-3,4,5-triol

C13H25NO6S2 (355.1123)


   

(3s,6r,8s,10s)-9-thia-11,15,20-triazaheptacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0⁵,²⁰.0¹⁷,²¹]docosa-1,11,13,15,17(21)-pentaene-6,8,13-triol

(3s,6r,8s,10s)-9-thia-11,15,20-triazaheptacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0⁵,²⁰.0¹⁷,²¹]docosa-1,11,13,15,17(21)-pentaene-6,8,13-triol

C18H17N3O3S (355.0991)


   

5-[(5s)-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl]-2h-1,3-benzodioxole-4-carboxylic acid

5-[(5s)-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl]-2h-1,3-benzodioxole-4-carboxylic acid

C19H17NO6 (355.1056)


   

(10r)-10-[(1s)-6,7-dihydroxy-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl]-3,5,11-trioxatricyclo[7.3.0.0²,⁶]dodeca-1(9),2(6),7-trien-12-one

(10r)-10-[(1s)-6,7-dihydroxy-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl]-3,5,11-trioxatricyclo[7.3.0.0²,⁶]dodeca-1(9),2(6),7-trien-12-one

C19H17NO6 (355.1056)


   

(2r,3r,4r,5r,6s)-2-{[(1z)-1-(hydroxyimino)-6-(methylsulfanyl)hexyl]sulfanyl}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4r,5r,6s)-2-{[(1z)-1-(hydroxyimino)-6-(methylsulfanyl)hexyl]sulfanyl}-6-(hydroxymethyl)oxane-3,4,5-triol

C13H25NO6S2 (355.1123)


   

5-{2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl}-2h-1,3-benzodioxole-4-carboxylic acid

5-{2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl}-2h-1,3-benzodioxole-4-carboxylic acid

C19H17NO6 (355.1056)